Amanda E Toland, PhD
College of Medicine
Cancer Biology and Genetics
Molecular Carcinogenesis and Chemoprevention
Breast Cancer ● Cancer ● Ovarian Cancer ● Carcinoma, Squamous Cell ● Colorectal Cancer ● Liposarcoma ● Colonic Cancer ● Aortic Stenosis, Supravalvular
Amanda Toland, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where her research focuses on identifying naturally occurring gene variations that affect cancer susceptibility, as well as mutations that drive tumors, in order to better prevent cancers in high-risk individuals, understand tumor growth and identify new targets for therapy and prevention.In particular, her work centers on the genetics of cutaneous squamous cell carcinoma, colorectal cancer and hereditary breast cancer. One of her recent studies found that variants in a gene important for eye color, OCA2, are associated with a shorter time to diagnosis of a skin cancer in solid organ transplant patients. Dr. Toland has co-authored many articles in well-respected publications, including Journal of Clinical Oncology, International Journal of Cancer, Nature Genetics, British Journal of Dermatology, and Breast Cancer Research.